Searched for
AMNEAL
India, Canada launch trade & investment forumIndia and Canada have launched a trade and investment forum to boost commercial engagement and enhance connectivity. Commerce Minister Piyu...- Piyush Goyal engages with over 50 industry leaders in New York to deepen India-US tradeIndia and the United States moved closer to deepening their trade ties as Union Minister of Commerce and Industry Piyush Goyal engaged with...
- Gland Pharma appoints Shyamakant Giri as new CEOShyamakant Giri has been appointed as the new CEO of Gland Pharma, effective January 15, 2025. Giri brings over 25 years of experience in t...
- US co Amneal plans units in India for weight-loss drugsAmneal Pharmaceuticals is set to invest $150-200 million over four to five years to build a manufacturing facility in Ahmedabad for weight ...
- Amneal Pharmaceuticals to invest up to USD 200 mn in India to set up 2 new plantsAmneal Pharmaceuticals announces a significant investment of up to USD 200 million in India over the next four to five years. The funds wil...
- Take advantage of Make in India in high-tech manufacturing: Piyush Goyal to US cosCommerce Minister Piyush Goyal invited American companies to invest in India's electronics, data infrastructure, and logistics sectors duri...
- US drugmaker Amneal bets big on India formulation businessThe $2 billion company by revenue promoted by NRI entrepreneur brothers Chirag Patel and Chintu Patel, has begun commercial operations in I...
- US drugmaker Amneal bets big on India's formulation marketThe drug maker even has plans to bring differentiated products based on novel drug delivery systems, biosimilars and specialty drugs from i...
- Amneal Pharma to set up plant in GujaratThe NYSE-listed, $2-billion drug maker by sales (2020), which is foraying into India's domestic formulations segment with focus on biologic...
- Amneal to enter Indian formulation mkt, to setup greenfield biologics plant in AhmedabadIn an interview to ET, Chirag Patel, Co-Chief Executive Officer of Amneal said that the company would hit the Indian market with its first ...
- US-based Amneal Pharmaceuticals buys India's injectable maker Punishka Healthcare for Rs 700 croresAmneal Pharmaceuticals on Tuesday said it has acquired Ahmedabad-based injectable drug maker Puniska Healthcare Pvt. Ltd for a total value ...
- Exit without serving notice period to attract 18% GST“We hold that the applicant is liable to pay GST at 18% under the entry of services not elsewhere classified, on recovery of notice pay fro...
- Nomura has a buy on Dr Reddy’s Labs, target price Rs 3,200The company has reported net profit after tax of Rs 1095.10 crore in the latest quarter.
- Analyst Calls: Dr Reddy’s Lab, Sun Pharma, Voltas, RILNomura has a buy rating on Dr Reddy’s Laboratories with a target price of Rs 3,200.
- Top stocks in focus on Friday, 1 September 2017Here is a list of top stocks that are likely to be in focus in today's trading session.
- Arrow Pharma acquires Australian operations of Amneal PharmaUnder the terms of the agreement, Arrow Pharmaceuticals will acquire 100 per cent of the issued capital of Amneal Pharmaceutical Pty Ltd Au...
- Lupin launches Amabelz tablets in US marketThe company's product is indicated in a woman with a uterus for treatment of moderate to severe vasomotor symptoms due to menopause and pre...
- Claris surges 18% as pharma cos in race to buy injectible bizLupin, Cipla Zydus Cadilla and US-based Amneal are competing with other global peers signaling the continuing appeal of quality Indian phar...
- India Inc's August foreign borrowings up over two-fold at $5.07 billionIndian companies had raised USD 2.31 billion from the foreign markets in the corresponding month a year ago in 2013.
- Indoco in JV to sell ophthalmic products in USIndoco Remedies has formalised a joint venture agreement with New Jersey-based Amneal Pharmaceuticals to market 10 ophthalmic products in t...
Load More
